UroGen Pharma Ltd.
URGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,347 | -$49,940 | -$43,843 | -$37,512 |
| Dep. & Amort. | $639 | $596 | $497 | $306 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,027 | $2,733 | $3,069 | $3,303 |
| Change in WC | -$10,059 | $5,206 | -$2,586 | $15,489 |
| Other Non-Cash | -$2,530 | $1,580 | $839 | $4,795 |
| Operating Cash Flow | -$42,270 | -$39,825 | -$42,024 | -$13,619 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$87 | -$141 | -$44 | -$115 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$66,351 | -$9,229 |
| Inv. Sales/Matur. | $0 | $0 | $40,432 | $69,965 |
| Other Inv. Act. | $31,485 | $28,547 | $0 | $0 |
| Investing Cash Flow | $31,398 | $28,406 | -$25,963 | $60,621 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$24,393 |
| Stock Issued | $0 | $0 | $34 | -$151,169 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,272 | $296 | $0 | $175,633 |
| Financing Cash Flow | $8,272 | $296 | $34 | $71 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,600 | -$11,123 | -$67,953 | $47,074 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $93,986 | $105,109 | $173,062 | $125,989 |
| End Cash | $91,386 | $93,986 | $105,109 | $173,063 |
| Free Cash Flow | -$42,357 | -$39,966 | -$42,068 | -$13,734 |